Watkins Tim Insider Trades

Insider Trading History

Track insider trading activity for Watkins Tim. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Contineum Therapeutics
Contineum Therapeutics CTNM
CMO & Head Of Development
Holding Value $131k 8,961 shares
Last Trade
Jun 30, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$174k 10,833 shares
$16.02
$14.57
Contineum Therapeutics
Contineum Therapeutics CTNM
CMO & Head Of Development
Holding Value $288k 19,794 shares
Last Trade
Jun 30, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$178k 10,833 shares
$16.39
$14.57
Contineum Therapeutics
Contineum Therapeutics CTNM
CMO & Head Of Development
Holding Value $3.47M 238,334 shares
Last Trade
Jun 30, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$178k 10,833 shares
$16.39
$14.57
Contineum Therapeutics
Contineum Therapeutics CTNM
CMO & Head Of Development
Holding Value $3.63M 249,167 shares
Last Trade
Mar 02, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$55.4k 3,611 shares
$15.34
$14.57
Contineum Therapeutics
Contineum Therapeutics CTNM
CMO & Head Of Development
Holding Value $52.6k 3,611 shares
Last Trade
Mar 02, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$55.4k 3,611 shares
$15.34
$14.57
Contineum Therapeutics
Contineum Therapeutics CTNM
CMO & Head Of Development
Holding Value $0 0 shares
Last Trade
Mar 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$54.2k 3,611 shares
$15.02
$14.57
Contineum Therapeutics
Contineum Therapeutics CTNM
CMO & Head Of Development
Holding Value $2.33M 160,000 shares
Last Trade
Jan 30, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.28M 160,000 shares
$14.26
$14.57
Contineum Therapeutics
Contineum Therapeutics CTNM
CMO & Head Of Development
Holding Value $11.8k 811 shares
Last Trade
Jan 28, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$51.2k 3,611 shares
$14.18
$14.57
Contineum Therapeutics
Contineum Therapeutics CTNM
CMO & Head Of Development
Holding Value $52.6k 3,611 shares
Last Trade
Jan 28, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$48.8k 3,611 shares
$13.53
$14.57
Contineum Therapeutics
Contineum Therapeutics CTNM
CMO & Head Of Development
Holding Value $3.68M 252,778 shares
Last Trade
Jan 28, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$48.8k 3,611 shares
$13.53
$14.57
Contineum Therapeutics
Contineum Therapeutics CTNM
CMO & Head Of Development
Holding Value $3.74M 256,389 shares
Last Trade
Dec 29, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$43.6k 3,611 shares
$12.07
$14.57
Contineum Therapeutics
Contineum Therapeutics CTNM
CMO & Head Of Development
Holding Value $52.6k 3,611 shares
Last Trade
Dec 29, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$43.6k 3,611 shares
$12.07
$14.57
Contineum Therapeutics
Contineum Therapeutics CTNM
CMO & Head Of Development
Holding Value $0 0 shares
Last Trade
Dec 29, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$43.5k 3,611 shares
$12.06
$14.57
Contineum Therapeutics
Contineum Therapeutics CTNM
CMO & Head Of Development
Holding Value $3.79M 260,000 shares
Last Trade
Apr 28, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.29M 286,000 shares
$4.50
$14.57

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up